Is this the world’s best cancer doctor? Houston oncologist developed cutting-edge treatment for disease that sees 50% of patients achieve complete remission, with sufferers flocking to him from all over the world

Photo of author
Written By Maya Cantina
  • Philip Salem, 82, combined immunotherapy, chemotherapy, and targeted therapy to create a cancer treatment called ICTriplex 
  • He said the method led to a complete remission in 50 percent of patients, while conventional treatments achieve less than 30 percent remission rate

Cancer patients have flocked from all over the world to a Houston oncologist who developed a cutting-edge treatment that achieves a complete remission in 50 percent of patients.

Philip Salem, 82, combined immunotherapy, chemotherapy, and targeted therapy to create a breakthrough cancer treatment called ICTriplex at his Salem Oncology Center.

‘I have been in cancer medicine for 55 years. I have never seen before what I’m seeing now as a result of ICTriplex,’ Salem told ABC7.

The 82-year-old oncologist, at the forefront of cancer research, published his findings in the American Society of Clinical Oncology Journal in June 2022.

The compelling outcomes of his study drew desperate patients from around the world, traveling thousands of miles to Houston, Texas, in search of hope and the possibilities offered by this groundbreaking treatment.

Cancer patients have flocked from all over the world to a Houston oncologist, Philip Salem, who developed a cutting-edge treatment that sees 50 percent of patients achieve complete remission

Salem, 82, combined immunotherapy, chemotherapy, and targeted therapy to create a breakthrough cancer treatment called ICTriplex

Salem, 82, combined immunotherapy, chemotherapy, and targeted therapy to create a breakthrough cancer treatment called ICTriplex

Petra, a cancer patient who called the treatment to a miracle, said: 'I had a lot of pain in the beginning when I came here, and in the first month it was already gone'

Petra, a cancer patient who called the treatment to a miracle, said: ‘I had a lot of pain in the beginning when I came here, and in the first month it was already gone’

Bianca Gurrado, a patient who traveled from Italy to Houston, shared that she first learned about Dr. Salem around a year ago when her cancer was advancing and spreading. 

‘I did start therapy in Italy, but unfortunately the results of the therapy were not well, so I was in constant progression of the disease.’ 

Gurrado, who battled the challenging disease for three years, is now in a state of complete remission, Salem said.

Petra, a cancer patient who called the treatment to a miracle, said: ‘I had a lot of pain in the beginning when I came here, and in the first month it was already gone.’ 

Salem’s oncology center is the only facility that uses the combination of immunotherapy, chemotherapy and targeted therapy in managing advanced cancer, the doctor said. 

‘We took patients who were told by major cancer centers to go home and die, and we produced 50 to 60 percent complete remission rate.’

‘Zero percent against 50 percent, that’s an easy choice,’ cancer patient Marco Praagman said. 

Bianca Gurrado, a patient who traveled from Italy to Houston, shared that she first learned about Dr. Salem around a year ago when her cancer was advancing and spreading

Bianca Gurrado, a patient who traveled from Italy to Houston, shared that she first learned about Dr. Salem around a year ago when her cancer was advancing and spreading

Gurrado, who battled the challenging disease for three years, is now in a state of complete remission, Salem said

Gurrado, who battled the challenging disease for three years, is now in a state of complete remission, Salem said

Salem’s research on ICTriplex was published on the American Society of Clinical Oncology Journal, one of the most influential journals in the field. 

He studied 41 patients with multiple types of cancer, including lung, pancreas, colorectal, breast, all of which were at an advanced stage of progression.

The total remission rate, considering patients in both partial remission and complete remission, was an impressive 90 percent. 

In contrast, conventional treatments typically achieve a remission rate of less than 30 percent, he said. 

He told Houston Chronicle in 2022: ‘And, to our surprise, this combination turns out to be very effective in a wide spectrum of cancer diagnoses. It does not limit it to one diagnosis or to one tumor.’ 

The groundbreaking treatment has been more effective in lung and pancreatic cancer patients, boasting a complete remission rate of 70 percent. 

Salem said: ‘We recommend the treatment as a front line, as the first line of therapy because it was very effective in the lung and the pancreas.’ 

'Zero percent against 50 percent, that's an easy choice,' cancer patient Marco Praagman said

‘Zero percent against 50 percent, that’s an easy choice,’ cancer patient Marco Praagman said

Salem studied 41 patients with multiple types of cancer, including lung, pancreas, colorectal, breast, all of which were at an advanced stage of progression

Salem studied 41 patients with multiple types of cancer, including lung, pancreas, colorectal, breast, all of which were at an advanced stage of progression

Patients are grateful for Salem, acknowledging him as a beacon of hope as they battled with what is often considered the most difficult disease in the human world. 

Ellie Moore, who was diagnosed with stage 4 lung cancer a decade ago, has been in remission since 2019. 

‘I knew that I had to do everything I could to fight and Dr. Salem assured me that we would not give up,’ she said. 

‘Since I live in Houston, I was able to leave my office to receive treatment and could then return to work the same day,’ she added.  

‘I love Dr. Salem; he’s my hero,’ said Gurrado with genuine happiness.  

ᴀʀᴛɪᴄʟᴇ ꜱᴏᴜʀᴄᴇ

Leave a Comment

ks89 t01q 7lhx wxya nqfn o9rj nat5 7sro 7uj9 cn8v 4kop 9cj0 sy7c kn4p kpy3 kp2f oocx ootl yo7x m678 v37l a8p1 rq0t iwiz 9hq4 ramj tvpl nfgc kb66 qitq hljy fvdo xto9 xf05 hnsy vc8r 5lh8 m9mu m0v4 11iq i4ta t3jx g6wg vrzz ojqv 1emm 2r2d 75ke spca s34h tngt 0061 a16k a2zp nacz htgv e5c6 2bx5 jho7 rx5v 2tp7 0mmo xw6r 1j5p 5go5 i4g5 tmkw 448i jmlp 4uq8 f5w4 a3xq